Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.
G. Mertz, L. Miedzinski, D. Goade, A. Pavia +10 more
2004Clinical Infectious Diseases191 citations
Semantic Scholar

